SUPN
Supernus Pharmaceuticals, Inc.
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2010-12-28
$28.15
+0.00 (+0.00%)
last quote
Want the full multi-source brief on SUPN?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$28.15
High
$31.62
Low
$27.97
Previous close
$28.15
Fundamentals
Market cap
$1.64B
P/E (TTM)
—
P/S (TTM)
1.97x
P/B
2.68x
Gross margin
88.30%
Operating margin
-15.71%
Net margin
-13.23%
Rev growth (YoY)
24.85%
EPS growth (YoY)
—
ROE
-10.42%
52W high
$59.68
52W low
$37.54
Beta
-0.35x
Industry peers
by market cap
Recent SEC filings
CIK 1356576filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 13h
Supernus Pharmaceuticals (SUPN) Stock May Be Undervalued After ONAPGO Exclusivity
Supernus Pharmaceuticals has had a mixed share price journey, with the stock up strongly over three years but weaker over the past year. That puts fresh attention on what investors are paying for its current level of sales. With new products, a merger closing and a changing revenue mix all in play, the central issue is how well the latest share price lines up with the sales the business is already
ChartMill · 16h
US Top Movers: Small-Cap Gainers and Losers in Today's Session
Today's US market movers include small-cap and microcap gainers such as RDAC, PARA and MERC, while VCIG, JAGX and XXII are among session losers.
Yahoo · 17h
What Changes For Supernus Pharmaceuticals (SUPN) After Its Nasdaq Delisting And Merger?
Supernus Pharmaceuticals (NasdaqGM:SUPN) has completed its merger of equals with Indivior Pharmaceuticals, forming a combined specialty pharma business. As part of the transaction, Supernus shares have been delisted from Nasdaq, with equity now rolling into the new merged entity. The deal includes consolidation of corporate structures and leadership roles, with governance now housed under a single
ChartMill · 18h
US Top Movers: Gainers and Losers for Nov. 3, 2026
US top movers for Nov. 3, 2026: PARA gained 133.0% and VCIG fell 40.07%, highlighting double-digit moves among the session's biggest gainers and losers.
ChartMill · 20h
US Stock Gap Movers: Up and Down Names in Today's Session
Today's US gap movers include RDAC up 116.0% and GMEX down 36.15%, with gap-up and gap-down tables covering sharp price moves from prior-session levels.
ChartMill · 22h
Premarket Movers: Gainers and Losers Ahead of November 3, 2026 U.S. Open
Premarket movers for November 3, 2026 include RDAC up 118.0%, MERC up 87.54%, VCIG down 37.25%, and SUPN down 31.18% ahead of the U.S. open.
Yahoo · 1d
Why Indivior Pharmaceuticals Stock Topped the Market Today
The company is merging with a peer.
Yahoo · 1d
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
Merger positions Supernus as a leading diversified central nervous system (CNS) biopharmaceutical company with a broad portfolio of marketed medicines, enhanced financial flexibility and a differentiated pipelineSignificantly enhances cash flow profile and scale, unlocking greater capacity to resource growth-driving products, advance CNS pipeline, and pursue strategic opportunitiesCombined entity
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial